ZA200810474B - Tablets comprising candesartan cilexetil - Google Patents

Tablets comprising candesartan cilexetil

Info

Publication number
ZA200810474B
ZA200810474B ZA200810474A ZA200810474A ZA200810474B ZA 200810474 B ZA200810474 B ZA 200810474B ZA 200810474 A ZA200810474 A ZA 200810474A ZA 200810474 A ZA200810474 A ZA 200810474A ZA 200810474 B ZA200810474 B ZA 200810474B
Authority
ZA
South Africa
Prior art keywords
tablets
candesartan cilexetil
cilexetil
candesartan
Prior art date
Application number
ZA200810474A
Other languages
English (en)
Inventor
Roehrich Tillmann
Bueb Waltraud
Schweinberger Enno
Original Assignee
Siegfried Generics Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37717552&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200810474(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Siegfried Generics Int Ag filed Critical Siegfried Generics Int Ag
Publication of ZA200810474B publication Critical patent/ZA200810474B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200810474A 2006-06-20 2008-12-10 Tablets comprising candesartan cilexetil ZA200810474B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH9982006 2006-06-20

Publications (1)

Publication Number Publication Date
ZA200810474B true ZA200810474B (en) 2009-09-30

Family

ID=37717552

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200810474A ZA200810474B (en) 2006-06-20 2008-12-10 Tablets comprising candesartan cilexetil

Country Status (9)

Country Link
US (1) US20090208583A1 (fr)
EP (1) EP2037891B1 (fr)
AR (1) AR061545A1 (fr)
AU (1) AU2007263351B2 (fr)
BR (1) BRPI0712197A2 (fr)
CA (1) CA2654493C (fr)
TW (1) TWI494134B (fr)
WO (1) WO2007147514A1 (fr)
ZA (1) ZA200810474B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9061207B2 (en) 2002-12-10 2015-06-23 Sony Computer Entertainment America Llc Temporary decoder apparatus and method
US20100041644A1 (en) 2006-11-28 2010-02-18 Laboratorios Liconsa, S. A. Stabilized solid pharmaceutical composition of candesartan cilexetil
MX2009010167A (es) * 2007-03-28 2009-10-12 Takeda Pharmaceutical Composicion farmaceutica solida que comprende un derivado de bencimidazol-7-carboxilato y un agente para el control del ph.
WO2009013237A2 (fr) * 2007-07-20 2009-01-29 Krka, D.D. Novo Mesto Composition pharmaceutique solide stable comprenant du candesartan ou ses formes pharmaceutiquement acceptables
EP2050440A1 (fr) * 2007-10-18 2009-04-22 Krka Composition pharmaceutique solide stable comprenant du candesartan ou ses formes pharmaceutiquement acceptables
EP2106789A1 (fr) * 2008-03-31 2009-10-07 KRKA, tovarna zdravil, d.d., Novo mesto Composition pharmaceutique comprenant du candesartan
US8355927B2 (en) 2010-11-05 2013-01-15 Genomind, Llc Neuropsychiatric test reports
HUP0900376A2 (en) 2009-06-19 2011-01-28 Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag Nanoparticulate candesartan cilexetil composition
JP2012149056A (ja) * 2010-12-28 2012-08-09 Kyorin Rimedio Co Ltd 新規な安定化固形製剤
WO2012149535A1 (fr) * 2011-04-29 2012-11-01 Genomind, Llc Utilisation d'antagoniste du récepteur de type 1 de l'angiotensine ii (at ii) dans le traitement thérapeutique de l'autisme
JP5917844B2 (ja) * 2011-06-24 2016-05-18 日本ケミファ株式会社 カンデサルタンシレキセチル製剤
EP2760473A1 (fr) * 2011-09-27 2014-08-06 Biomed Valley Discoveries, Inc. Compositions et méthodes de traitement des gliomes
JP6076406B2 (ja) * 2015-06-15 2017-02-08 日本ケミファ株式会社 カンデサルタンシレキセチル製剤
KR101769293B1 (ko) * 2016-09-30 2017-08-30 주식회사 종근당 칸데사르탄 및 암로디핀을 포함하는 단일층으로 이루어진 복합제
JP6346314B2 (ja) * 2017-01-10 2018-06-20 日本ケミファ株式会社 カンデサルタン シレキセチル製剤
JP2018141011A (ja) * 2018-05-24 2018-09-13 日本ケミファ株式会社 カンデサルタン シレキセチル製剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69942777D1 (de) * 1998-07-28 2010-10-28 Takeda Pharmaceutical Leicht zerfallende feste Zubereitung
US20040005358A1 (en) * 2002-04-23 2004-01-08 Slugg Peter H. Modified-release vasopeptidase inhibitor formulation, combinations and method
WO2005079751A2 (fr) * 2004-01-23 2005-09-01 Ranbaxy Laboratories Limited Compositions pharmaceutiques orales de candesartan cilexetil
WO2005084648A1 (fr) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited Compositions pharmaceutiques comprenant du candesartan cilexetil
ES2371145T3 (es) * 2005-01-26 2011-12-27 Lek Pharmaceuticals D.D. Nueva composición farmacéutica que contiene candesartán cilexetilo como sustancia cristalina lipófila.
US9149439B2 (en) * 2005-03-21 2015-10-06 Sandoz Ag Multi-particulate, modified-release composition

Also Published As

Publication number Publication date
EP2037891A1 (fr) 2009-03-25
US20090208583A1 (en) 2009-08-20
AU2007263351A1 (en) 2007-12-27
AR061545A1 (es) 2008-09-03
TW200815049A (en) 2008-04-01
CA2654493A1 (fr) 2007-12-27
BRPI0712197A2 (pt) 2012-01-10
WO2007147514A1 (fr) 2007-12-27
TWI494134B (zh) 2015-08-01
EP2037891B1 (fr) 2012-10-24
AU2007263351B2 (en) 2013-02-07
AU2007263351A2 (en) 2009-05-28
CA2654493C (fr) 2015-11-24

Similar Documents

Publication Publication Date Title
ZA200810474B (en) Tablets comprising candesartan cilexetil
IL197093A0 (en) Pharmaceutical composition comprising candesartan cilexetil
IL194355A0 (en) Orally disintegrating tablets
ZA201002255B (en) Orodispersible tablets
EP2017071A4 (fr) Presse a commande inférieure
IL196101A0 (en) C-phenyl 1-thioglucitol compound
EP2088861A4 (fr) Composés de benzimidazole
AU309481S (en) A tablet
EP2034804A4 (fr) Dispositif empêchant la décharge
IL176140A0 (en) Candesartan cilexetil polymorphs
SI2040684T1 (sl) Večenotne tablete
EP1778650A4 (fr) Processus de fabrication de candésartan cilexétil
HK1138739A1 (en) Compact case
ZA200904654B (en) Tablet formulation
AU315240S (en) Lavatory
GB0605104D0 (en) Tablet dispenser
PL2425947T3 (pl) Urządzenie do prasowania włókna
AU315239S (en) Lavatory
EP1984356A4 (fr) Procédé amélioré pour la préparation de candésartan cilexetil
AU315241S (en) Lavatory
GB0608465D0 (en) Tablet dispenser
EP2050456A4 (fr) Comprimé
GB2441742B (en) Orthotics
GB0620112D0 (en) Detergent tablets
WO2008068727A3 (fr) Composition pharmaceutique comprenant du candésartan cilexétil